Addressing large, unmet global markets with innovative proprietary products More »
Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »
Identifying early-stage companies with potential to increase value for shareholders More »
OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors.
OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP) more »
OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference more »
OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference more »
OPKO Health is an opportunistic research and development company that targets large, high-growth markets.